Adenovirus-36 Seropositivity and Its Relation with Obesity and Metabolic Profile in Children

The human adenovirus 36 (Ad-36) is causally and correlatively associated in animals and humans, respectively, with increased adiposity and altered metabolic profile. In previous studies, the relationship between Ad-36 seropositivity with obesity was established in adults and children. We evaluated the association of positive antibodies to Ad-36 with obesity and metabolic profile in Mexican children. Seventy-five children with normal-weight and 82 with obesity were studied in this research. All children had a clinic assessment which included weight, height, body circumferences, and skinfold thickness. Laboratory analyzes included triglycerides, total cholesterol, high-density lipoprotein, low-density lipoprotein, and glucose and insulin levels. An enzyme-linked immunosorbent assay (ELISA) was used to determine the antibodies to Ad-36 in the serum samples. The overall Ad-36 seroprevalence was 73.9%. Ad-36 seropositivity had a higher prevalence in obese children than in normal weight group (58.6 versus 41.4%, P=0.007). Ad-36 seropositivity was associated with obesity (OR=2.66, P=0.01) and high-density lipoprotein <40 mg/dL (OR=2.85, P=0.03). The Ad-36 seropositive group had greater risk of 4 metabolic abnormalities compared with those children without none alteration. In summary, Ad-36 seropositivity was associated with obesity and low HDL-c levels in the sample of children studied

Interleukin-6 Gene Promoter Polymorphisms and Cardiovascular Risk Factors. A family study

Objective: To determine whether the advanced paternal age associated factor for bipolar disorder in patients attended at the Regional Teaching Hospital of Cajamarca. Material and Methods: An observational, retrospective, case-control study was conducted. The study population consisted of 136 adult patients with; Which were divided into 2 groups: with or without bipolar disorder; The odds ratio and chi-square test were calculated. Results: There were no significant differences regarding the variables age, gender or origin among patients with or without bipolar disorder. The frequency of advanced paternal age in patients with bipolar disorder was 20%. The frequency of advanced paternal age in patients without bipolar disorder was 9%. Advanced paternal age is a associated factor for bipolar disorder with an odds ratio of 2.67 which was significant (p <0.05). Conclusions: The advanced paternal age associated factor for bipolar disorder in patients attended at the Regional Teaching Hospital of Cajamarca.Objetivo: Determinar si la edad paterna avanzada es factor asociado para trastorno bipolar en pacientes atendidos en el Hospital Regional Docente de Cajamarca. Material y Métodos: Se llevó a cabo un estudio de tipo observacional, retrospectivo de casos y controles. La población de estudio estuvo constituida por 136 pacientes adultos con; las cuales fueron divididas en 2 grupos: con trastorno bipolar o sin él; se calculó el odds ratio y la prueba chi cuadrado. Resultados: No se apreciaron diferencias significativas respecto a las variables edad, genero ni procedencia entre los pacientes con trastorno bipolar o sin él. La frecuencia de edad paterna avanzada en los pacientes con trastorno bipolar fue de 20%. La frecuencia de edad paterna avanzada en los pacientes sin trastorno bipolar fue de 9%. La edad paterna avanzada es factor asociado para trastorno bipolar con un odds ratio de 2.67 el cual fue significativo (p<0.05). Conclusiones: La edad paterna avanzad es factor asociado para trastorno bipolar en pacientes atendidos en el Hospital Regional Docente de Cajamarca

HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations

Background Cervical cancer (CC) is the fourth leading cause of death from neoplasms in women and is caused by the human papilloma virus (HPV). Several methods have been developed for the screening of cervical lesions and HPV; however, some socio-cultural factors prevent women from undergoing gynecological inspection, which results in a higher risk of mortality from cervical cancer in certain population groups as indigenous communities. This study aimed to compare the concordance in HPV detection from urine and cervical samples, to propose an alternative to cervical scraping, which is commonly used in the cervical cancer screening. Methodology The DNA from cervical scrapings and urine samples was extracted using the proteinase K method followed by precipitation with alcohol, phenol andchloroform; a modification of the proteinase K method was developed in the management of urine sediment. Viral genotyping was performed using INNOLipa. Results The study population consisted of 108 patients from an indigenous population at southern Mexico, 32 without squamous intraepithelial lesions (NSIL) and 76 with low squamous intraepithelial lesions (LSIL). The majority of NSIL cervical scrapes were negative for HPV (90.63%), whereas more than half of LSIL cases were high-risk HPV positive (51.32%), followed by multiple infection by HR-HPV (17.11%), and multiple infection by LR- and HR-HPV (9.21%). No statistically significant relationship between the cytological diagnosis and the HPV genotypes detected in the urine samples was observed. A concordance of 68.27% for HPV positivity from urine and cervical samples was observed. Similarly, a concordance of 64.52% was observed in the grouping of HPVs by oncogenic risk. HR-HPV was detected in 71% of the urine samples from women with LSIL diagnosis, which suggests that HR-HPV detected in a urine sample could indicate the presence or risk of developing SIL. Conclusion HR-HPV detection in urine samples could be an initial approach for women at risk of developing LSIL and who, for cultural reasons, refuse to undergo a gynecological inspection

Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children

<p>Abstract</p> <p>Background</p> <p>Several association studies have shown that -844 G/A and <it>HindIII </it>C/G <it>PAI-1 </it>polymorphisms are related with increase of PAI-1 levels, obesity, insulin resistance, glucose intolerance, hypertension and dyslipidemia, which are components of metabolic syndrome. The aim of this study was to analyze the allele and genotype frequencies of these polymorphisms in <it>PAI-1 </it>gene and its association with metabolic syndrome and its components in a sample of Mexican mestizo children.</p> <p>Methods</p> <p>This study included 100 children with an age range between 6-11 years divided in two groups: a) 48 children diagnosed with metabolic syndrome and b) 52 children metabolically healthy without any clinical and biochemical alteration. Metabolic syndrome was defined as the presence of three or more of the following criteria: fasting glucose levels ≥ 100 mg/dL, triglycerides ≥ 150 mg/dL, HDL-cholesterol < 40 mg/dL, obesity BMI ≥ 95^thpercentile, systolic blood pressure (SBP) and diastolic blood pressure (DBP) ≥ 95^thpercentile and insulin resistance HOMA-IR ≥ 2.4. The -844 G/A and <it>HindIII </it>C/G <it>PAI-1 </it>polymorphisms were analyzed by PCR-RFLP.</p> <p>Results</p> <p>For the -844 G/A polymorphism, the G/A genotype (OR = 2.79; 95% CI, 1.11-7.08; <it>p </it>= 0.015) and the A allele (OR = 2.2; 95% CI, 1.10-4.43; <it>p </it>= 0.015) were associated with metabolic syndrome. The -844 G/A and A/A genotypes were associated with increase in plasma triglycerides levels (OR = 2.6; 95% CI, 1.16 to 6.04; <it>p </it>= 0.02), decrease in plasma HDL-cholesterol levels (OR = 2.4; 95% CI, 1.06 to 5.42; <it>p </it>= 0.03) and obesity (OR = 2.6; 95% CI, 1.17-5.92; <it>p </it>= 0.01). The C/G and G/G genotypes of the <it>HindIII </it>C/G polymorphism contributed to a significant increase in plasma total cholesterol levels (179 vs. 165 mg/dL; <it>p </it>= 0.02) in comparison with C/C genotype.</p> <p>Conclusions</p> <p>The -844 G/A <it>PAI-1 </it>polymorphism is related with the risk of developing metabolic syndrome, obesity and atherogenic dyslipidemia, and the <it>HindIII </it>C/G <it>PAI-1 </it>polymorphism was associated with the increase of total cholesterol levels in Mexican children.</p

Polimorfismos g-2548a en el gen de leptina y q223r en el gen del receptor de leptina: una revisión de su relación con el sobrepeso y la obesidad

La obesidad es una enfermedad compleja y multifactorial resultante de efectos combinados entre genes, ambiente y estilo de vida que influyen en la respuesta individual a la dieta y la actividad física, generando aumento de la adiposidad y por lo tanto del índice de masa corporal (IMC). Se considera una pandemia por encontrarse diseminada a nivel mundial, con aumento constante de su prevalencia y de complicaciones metabólicas asociadas a enfermedades crónicas no transmisibles (ECNT). La leptina (LEP) y el receptor de leptina (LEPR) son genes que han sido evaluados en la búsqueda de variantes que podrían estar relacionadas con la obesidad y sus complicaciones cardiometabólicas. La presente es una descripción narrativa de literatura cuyo objetivo es revisar el conocimiento actual sobre la relación de los polimorfismos de un solo nucleótido (SNPs) LEP G2548A (rs7799039) y LEPR Q223R (rs1137101) con la obesidad y el sobrepeso, según elIMC. Se realizaron búsquedas en las bases de datos de publicaciones desde el2015 a la fecha, en español e inglés, en NCBI PubMed, Google Scholar y SCOPUS. Se revisaron 90 artículos, de las cuales se eligieron las publicaciones para la presente revisión. Se encontraron revisiones de suma importancia donde se reporta la asociación de los polimorfismos de LEP y LEPR con la presencia de sobrepeso y obesidad. Sin embargo, no se cuenta con este tipo de información en población guatemalteca, lo que pone en perspectiva su relevancia para su investigación

Pruebas presuntivas del análisis de orina en el diagnóstico de infección en vías urinarias entre diabéticos tipo 2

Objetivo. Determinar la confiabilidad de las pruebas presuntivas del análisis de orina en el diagnóstico temprano de infecciones de vías urinarias entre pacientes con diabetes tipo 2. Material y métodos. En el año 2001 se realizó un estudio transversal entre 160 diabéticos con diagnóstico clínico de infección en vías urinarias, de la ciudad de Tlapa, Guerrero. Se confirmó este diagnóstico por urocultivo, se comparó con las pruebas presuntivas de esterasa leucocitaria, nitritos, cuenta de leucocitos y bacteriuria en orina centrifugada y sin centrifugar. Se calculó la sensibilidad, la especificidad, el valor predictivo positivo y el negativo. Resultados. En 31% de los participantes se confirmó infección urinaria. La presencia de bacterias en orina centrifugada, esterasa leucocitaria y la cuenta de leucocitos presentaron sensibilidad y especificidad altas. Conclusiones. Las mediciones de esterasa leucocitaria y bacteriuria en orina centrifugada ofrecen confiabilidad en el diagnóstico oportuno de infecciones de vías urinarias